Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center, New York

Albert Einstein College of Medicine, The Bronx

Southeastern Regional Medical Center, Newnan

Northwestern University, Chicago

Texas Oncology, P.A., Dallas

UT Southwestern Medical Center, Dallas

University of Texas MD Anderson Cancer Center, Houston

Mays Cancer Center, San Antonio

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston

National Hospital Organization Hokkaido Cancer Center, Sapporo

National Cancer Center Hospital East, Chiba

Fukushima Medical University Hospital, Fukushima

Local Independent Administrative Corporation Hiroshima City Hospital Organization Hiroshima City Hiroshima Citizens Hospital, Hiroshima

Hakuaikai Social Medical Corporation Sagara Hospital, Kagoshima

Kanagawa Cancer Center, Kanagawa

Kumamoto University Hospital, Kumamoto

Aichi Cancer Center Hospital, Nagoya

Nagoya City University Hospital, Nagoya

National Hospital Organization Osaka National Hospital, Osaka

Osaka International Cancer Institute, Osaka

Kindai University Hospital, Osaka

Saitama Medical University International Medical Center, Saitama

Saitama Cancer Center, Saitama

National Cancer Center Hospital, Tokyo

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo